Clinical Trials Logo
  1. Home
  2. Arthralgia
  3. NCT00660244
  4. Details
NCT00660244 Clinical Trial

Breast Cancer Tumor Care Observational Programme

Arthralgia Clinical Trial

Official title:
Breast Cancer Tumor Care Patient Observation Programme

Clinical Trial Details — Status: Completed

Administrative data
NCT number NCT00660244
Other study ID # NIS-OAT-ARI-2007/1
Secondary ID
Status Completed
Phase N/A
First received April 15, 2008
Last updated June 5, 2012
Start date February 2008
Est. completion date December 2009

Study information
Verified date June 2012
Source AstraZeneca
Contact n/a
Is FDA regulated No
Health authority Austria: Agency for Health and Food Safety
Study type Observational

Clinical Trial Summary

The purpose of this study is to investigate efficacy and tolerability under anastrozole (Arimidex) treatment.

Recruitment information / eligibility
Status Completed
Enrollment 150
Est. completion date December 2009
Est. primary completion date
Accepts healthy volunteers No
Gender Female
Age group N/A and older
Eligibility Inclusion Criteria:

- Postmenopausal women

- Already on upfront Arimidex Therapy (Start 1-4 weeks before)

- HR+

Exclusion Criteria:

- Premenopausal women

- Tamoxifen switch patients

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

Intervention

Drug:
• anastrozole
Oral

Locations
Country Name City State
Austria Research Site Graz

Sponsors (1)
Lead Sponsor Collaborator
AstraZeneca

Country where clinical trial is conducted

Austria, 

Outcome
Type Measure Description Time frame Safety issue
Primary Progression of disease and tolerability in general Baseline, every 3 month No
Secondary Patient questionnaire to collect data on Incidence, time of onset and treatment of arthralgia Baseline, every 3 month No
See also
  Status Clinical Trial Phase
Completed NCT03802578 - The Impact of Exercise on Hand Function, Daily Activities Performance and Quality of Life of SLE' Patients N/A
Completed NCT01896050 - Loss of Grip Strength, BMI, and Adjuvant Endocrine Therapy Breast Cancer N/A
Recruiting NCT04354649 - Immune-Mediated Pathophysiology And Clinical Triage Program Phase 2
Terminated NCT00973141 - A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Osteoarthritis-related Pain Phase 2
Recruiting NCT05564182 - High Intensity Laser Therapy in the Treatment of Hemiplegic Shoulder Pain N/A
Recruiting NCT05033613 - Home Blood Pressure Monitoring Before and After COVID-19 Vaccination in Patients at High Risk of Cardiovascular Disease
Recruiting NCT03953157 - Dietary and Exercise Interventions in Reducing Side Effects in Patients With Stage I-IIIa Breast Cancer Receiving Aromatase Inhibitors N/A
Terminated NCT02947022 - Effects of IV-Administered Ca-DTPA and Zn-DTPA To Treat Patients With Gadolinium Deposition Disease Phase 1/Phase 2
Terminated NCT02047851 - Randomized, Blinded, Sham-controlled Trial of Acupuncture for the Management of Joint Pain in Patients With Psoriasis N/A
Withdrawn NCT01612728 - Treatment for Joint Pains Due to Aromatase Inhibitor Therapy in Breast Cancer Phase 2
Completed NCT02118636 - Observational Study to Evaluate Mechanisms of Aromatase Inhibitor Associated Musculoskeletal Symptoms N/A
Completed NCT00361582 - A Study to Evaluate the Effectiveness and Safety of Multiple Doses of Tapentadol(CG5503) in Patients Awaiting Joint Replacement Surgery Phase 3
Completed NCT00416715 - Vitamin D Deficiency, Muscle Pain, Joint Pain, and Joint Stiffness in Postmenopausal Women Receiving Letrozole For Stage I-III Breast Cancer Phase 2
Completed NCT02831582 - Omega-3 Supplementation in Prevention of Aromatase Inhibitor-Induced Toxicity in Patients With Stage I-III Breast Cancer N/A
Recruiting NCT04494412 - An Intravenous (IV) Zanamivir Pharmacokinetics (PK) Study in Hospitalized Neonates and Infants With Influenza Infection Phase 2
Not yet recruiting NCT06134050 - Finding the Optimal Aim of Correction in Opening Wedge High Tibial Osteotomy N/A
Completed NCT02589249 - The Effect of AyuFlex® Supplementation on Joint Health N/A
Completed NCT02778906 - Abatacept Reversing Subclinical Inflammation as Measured by MRI in ACPA Positive Arthralgia Phase 3
Terminated NCT01096407 - Role of Biomarkers in Muscle Pain and Joint Pain in Patients With Solid Tumors Receiving Paclitaxel Phase 1
Terminated NCT04164563 - Even-Up to Minimize Secondary Site Pain For Ankle Fracture N/A